TPS05--Biomarkers of Disease Severity & Outcome Measures of Therapeutic Efficacy | Theater A Exhibit Hall
TPS05.5- Maximizing benefits with early CFTR modulator treatment: Lower sweat chloride is associated with improved clinical outcomes in children aged 6 to 11 years